a month ago
RARE
AnalystsWhitney IjemWhitney Ijem's Stock Forecasts
AnalystsWhitney Ijem
Sectors:
Industries:
Analyst Ranking
Top 6%
#313 out of 5511 analysts
Average Return
+21.55%
Win Rate
47%69 out of 147
Risk vs Reward
Poor
Good
Whitney Ijem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | +606.98% | $12.03 | $85.05 | 2020-02-07 - 2021-02-05 | Strong Buy |
Palvella Therapeutics IncPVLA | +584.04% | $18.80 | $128.60 | 2025-02-26 - 2026-02-25 | Strong Buy |
Regulus Therapeutics IncRGLS | +482.48% | $1.37 | $7.98 | 2025-03-17 - 2025-04-30 | Strong Buy |
Palvella Therapeutics IncPVLA | +418.10% | $22.05 | $114.24 | 2025-05-16 - 2026-05-15 | Strong Buy |
Palvella Therapeutics IncPVLA | +346.35% | $26.97 | $120.38 | 2025-04-02 - 2026-04-01 | Strong Buy |
Whitney Ijem Analyst Color
Get additional color on Whitney Ijem's coverage of popular stocks
a month ago
BBIO
a month ago
BMRN
a month ago
PHAR
3 months ago
RYTM
4 months ago
RYTM
4 months ago
BMRN
5 months ago
TSHA
6 months ago
WVE
7 months ago
BMRN
7 months ago
ALNY
7 months ago
WVE
8 months ago
BMRN
9 months ago
PVLA
9 months ago
RYTM
9 months ago
WVE
10 months ago
GUTS
10 months ago
PVLA
10 months ago
RYTM
a year ago
PVLA
a year ago
PVLA
a year ago
TSHA
a year ago
ALNY
a year ago
RYTM
a year ago
TSHA
Whitney Ijem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Belite Bio IncBLTE | 1 | Strong Buy | $303.00 | +79.07% | Initiates Coverage On | 13 days ago |
Ultragenyx Pharmaceutical IncRARE | 12 | Strong Buy | $37.00 | +187.27% | Maintains | 14 days ago |
Neurogene IncNGNE | 3 | Strong Buy | $166.00 | +378.80% | Maintains | a month ago |
Bridgebio Pharma IncBBIO | 2 | Strong Buy | $106.00 | +55.20% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 13 | Strong Buy | $114.00 | +76.12% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 13 | Hold | $442.00 | -13.88% | Maintains | a month ago |
Pharming Group NvPHAR | 2 | Strong Buy | $38.00 | +258.49% | Maintains | a month ago |
Tenax Therapeutics IncTENX | 1 | Strong Buy | $35.00 | +1,823.08% | Initiates Coverage On | 2 months ago |
Rhythm Pharmaceuticals IncRYTM | 13 | Strong Buy | $151.00 | +54.07% | Maintains | 3 months ago |
Intellia Therapeutics IncNTLA | 10 | Strong Buy | $49.00 | +326.46% | Maintains | 3 months ago |
Ocugen IncOCGN | 2 | Strong Buy | $11.00 | +1,002.20% | Maintains | 4 months ago |
Wave Life Sciences IncWVE | 5 | Strong Buy | $43.00 | +854.50% | Maintains | 5 months ago |
Taysha Gene Therapies IncTSHA | 12 | Strong Buy | $17.00 | +235.31% | Maintains | 5 months ago |
Fractyl Health IncGUTS | 3 | Strong Buy | $8.00 | +1,323.49% | Maintains | 6 months ago |
Arcturus Therapeutics Holdings IncARCT | 7 | Strong Buy | $21.00 | +34.62% | Maintains | 6 months ago |
Passage Bio IncPASG | 8 | Strong Buy | $23.00 | +373.25% | Maintains | 6 months ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $74.00 | +220.35% | Initiates Coverage On | 7 months ago |
Alnylam Pharmaceuticals IncALNY | 10 | Strong Buy | $429.00 | +79.23% | Maintains | 7 months ago |
Tenaya Therapeutics IncTNYA | 7 | Strong Buy | $5.00 | +659.88% | Maintains | 9 months ago |
Palvella Therapeutics IncPVLA | 8 | Strong Buy | $204.00 | +34.72% | Maintains | 9 months ago |
Generation Bio CoGBIO | 3 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Rocket Pharmaceuticals IncRCKT | 9 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Verve Therapeutics IncVERV | 6 | Hold | $13.00 | N/A | Downgrades | a year ago |
Regulus Therapeutics IncRGLS | 6 | Hold | $11.00 | N/A | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 2 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Sigilon Therapeutics IncSGTX | 2 | Strong Buy | $30.00 | N/A | Maintains | 3 years ago |
Neubase Therapeutics IncNBSE | 1 | Strong Buy | $260.00 | N/A | Initiates Coverage On | 7 years ago |
Gilead Sciences IncGILD | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Karyopharm Therapeutics IncKPTI | 4 | Strong Buy | $240.00 | N/A | Upgrades | 7 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.